179 related articles for article (PubMed ID: 32868339)
1. Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.
Zhao LP; Papadopoulos GK; Kwok WW; Moustakas AK; Bondinas GP; Carlsson A; Elding Larsson H; Ludvigsson J; Marcus C; Samuelsson U; Wang R; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å
Diabetes; 2020 Nov; 69(11):2523-2535. PubMed ID: 32868339
[TBL] [Abstract][Full Text] [Related]
2. Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children.
Zhao LP; Papadopoulos GK; Kwok WW; Moustakas AK; Bondinas GP; Larsson HE; Ludvigsson J; Marcus C; Samuelsson U; Wang R; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å
Diabetes; 2020 Jul; 69(7):1573-1587. PubMed ID: 32245799
[TBL] [Abstract][Full Text] [Related]
3. Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden.
Zhao LP; Papadopoulos GK; Moustakas AK; Bondinas GP; Carlsson A; Larsson HE; Ludvigsson J; Marcus C; Persson M; Samuelsson U; Wang R; Pyo CW; Geraghty DE; Lernmark Å
Sci Rep; 2021 Apr; 11(1):8821. PubMed ID: 33893332
[TBL] [Abstract][Full Text] [Related]
4. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles.
Ettinger RA; Papadopoulos GK; Moustakas AK; Nepom GT; Kwok WW
J Immunol; 2006 Feb; 176(3):1988-98. PubMed ID: 16424231
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1.
Zhao LP; Skyler J; Papadopoulos GK; Pugliese A; Najera JA; Bondinas GP; Moustakas AK; Wang R; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å
Diabetes Care; 2022 Jul; 45(7):1610-1620. PubMed ID: 35621697
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.
van Lummel M; van Veelen PA; Zaldumbide A; de Ru A; Janssen GM; Moustakas AK; Papadopoulos GK; Drijfhout JW; Roep BO; Koning F
J Biol Chem; 2012 Mar; 287(12):9514-24. PubMed ID: 22184118
[TBL] [Abstract][Full Text] [Related]
7. HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6.
Luo S; Lin J; Xie Z; Xiang Y; Zheng P; Huang G; Li X; Liao Y; Hagopian WA; Wang CY; Zhou Z
J Clin Endocrinol Metab; 2016 Apr; 101(4):1693-700. PubMed ID: 26866570
[TBL] [Abstract][Full Text] [Related]
8. Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus.
Ettinger RA; Liu AW; Nepom GT; Kwok WW
J Immunol; 2000 Sep; 165(6):3232-8. PubMed ID: 10975839
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
11. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
[TBL] [Abstract][Full Text] [Related]
12. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus.
Sanjeevi CB; Landin-Olsson M; Kockum I; Dahlquist G; Lernmark A
Tissue Antigens; 1995 Feb; 45(2):148-52. PubMed ID: 7792764
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
14. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.
Stayoussef M; Benmansour J; Al-Irhayim AQ; Said HB; Rayana CB; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2009 Aug; 16(8):1146-50. PubMed ID: 19553558
[TBL] [Abstract][Full Text] [Related]
16. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes.
Bratanic N; Smigoc Schweiger D; Mendez A; Bratina N; Battelino T; Vidan-Jeras B
Tissue Antigens; 2010 Sep; 76(3):208-15. PubMed ID: 20492597
[TBL] [Abstract][Full Text] [Related]
17. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
[TBL] [Abstract][Full Text] [Related]
18. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes.
Undlien DE; Kockum I; Rønningen KS; Lowe R; Saanjeevi CB; Graham J; Lie BA; Akselsen HE; Lernmark A; Thorsby E
Tissue Antigens; 1999 Dec; 54(6):543-51. PubMed ID: 10674967
[TBL] [Abstract][Full Text] [Related]
19. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
20. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
